Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zweidler

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Stem Cells (Dayton, Ohio)|June 23, 2009
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cellsDavid Steiner, Juri Gelovani, Barbara Savoldo, et al.
The Journal of Experimental Medicine|January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approachSankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansionDongxia Xing, Alan G Ramsay, John G Gribben, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Haematologica|December 15, 2018
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COGMichael J Burke, Wanda L Salzer, Meenakshi Devidas, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Experimental Hematology|February 7, 2012
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) miceSimon N Robinson, Paul J Simmons, Michael W Thomas, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|June 23, 2009
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cellsDavid Steiner, Juri Gelovani, Barbara Savoldo, et al.
The Journal of Experimental Medicine|January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approachSankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansionDongxia Xing, Alan G Ramsay, John G Gribben, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Haematologica|December 15, 2018
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COGMichael J Burke, Wanda L Salzer, Meenakshi Devidas, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Experimental Hematology|February 7, 2012
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) miceSimon N Robinson, Paul J Simmons, Michael W Thomas, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Pageof 8